SightfileU.S. market data from official filings

IMMATICS N.V (IMTX)

Name: IMMATICS N.V (IMTX) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001809196 · EDGAR filings · Updated 2026-06-25

IMMATICS N.V (IMTX) has reported institutional ownership of 80.7%, with 83 institutional managers holding positions valued at $1.06B per the latest 13F reporting period.

Institutional ownership

80.7%

Institutional managers

Reported 13F value

$1.06B

Latest updates

2026-06-25 — Employee-plan registration (S-8) filed
2026-06-18 — Insider transaction reported (Form 4)
2026-06-18 — Insider transaction reported (Form 4)
2026-06-18 — Insider transaction reported (Form 4)
2026-06-18 — Insider transaction reported (Form 4)
2026-06-18 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, IMMATICS N.V has 83 institutional holders and institutional ownership of 80.7%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 8 reporting insiders, with a net reported value of $0.

Related companies

ZENAS BIOPHARMA INC (ZBIO) · AURINIA PHARMACEUTICALS INC (AUPH) · NOVOCURE LTD (NVCR) · RECURSION PHARMACEUTICALS IN (RXRX) · CAPRICOR THERAPEUTICS INC (CAPR) · CORVUS PHARMACEUTICALS INC (CRVS)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-25.